The Second People’s Hospital of Lianyungang | China
Prof. Anquan Shang is a distinguished Associate Chief Laboratory Technician and Clinical Laboratory Physician with an H-index of 26. At the age of 39, he has made significant contributions to the field of clinical laboratory diagnostics. As a master’s supervisor, he plays a crucial role in mentoring future medical professionals. He is currently affiliated with Shanghai Jiao Tong University and has extensive experience in tumor marker research and clinical diagnostics.
Profile👤
ORCID
Google Scholar
Scopus
Strengths for the Awards✨
-
Strong Research Productivity
- H-index of 26, indicating high citation impact.
- Over 70 SCI and core journal publications as first or corresponding author.
- Multiple high-impact factor papers in oncology, microbiology, and immunology.
-
Impressive Funding & Grants
- Secured multiple national and provincial-level research grants.
- Led and participated in 13+ major projects in oncology, infection, and precision diagnostics.
-
Leadership & Recognition
- Head of key clinical departments and training programs in prestigious hospitals.
- Recognized in Shanghai and Jiangsu talent programs, highlighting academic excellence.
-
Significant Innovations & Impact
- Contributions to liquid biopsy, tumor biomarkers, and infection diagnostics.
- 5+ patents, demonstrating translational research impact.
-
Professional Network & Influence
- Active in national and international research communities.
- Reviewer and editor for multiple scientific journals.
🎓 Education
His academic journey began with a specialization in medical laboratory technology at Xiangfan Vocational and Technical College (2005-2008). He then pursued a bachelor’s degree in medical laboratory science at Jiangsu University (2011-2014), followed by a master’s degree in clinical laboratory diagnostics at Ningxia Medical University (2014-2017). He furthered his expertise with a Ph.D. in clinical laboratory diagnostics from Tongji University (2017-2020), establishing a strong foundation for his research career.
🏥 Experience
Currently, he is a postdoctoral researcher in clinical laboratory diagnostics at Ruijin Hospital, affiliated with Shanghai Jiao Tong University (2025-present), focusing on tumor biomarker research. Since 2023, he has led the Clinical Laboratory Medicine Department at Lianyungang Second People’s Hospital, a key clinical specialty in Jiangsu Province. Previously, he completed another postdoctoral fellowship at Tongji University (2020-2022), researching tumor microenvironment and biomarkers. His clinical experience spans roles as a laboratory technician at various hospitals between 2008 and 2014, steadily advancing to leadership positions.
🔬 Research Interests On Medicine
His research focuses on:
1️⃣ Tumor immunology 🧬
2️⃣ Infection microecology and immune microenvironment remodeling 🦠
3️⃣ Precision molecular diagnostics for chronic diseases 🏥
4️⃣ Liquid biopsy techniques for early disease detection 💉
🏆 Awards
He has received numerous prestigious awards, including the Yancheng City Natural Science Achievement Award (3 times), the Yancheng Medical New Technology Introduction Award (5 times), and the Huaihai Science and Technology Progress Award (2nd Prize, twice). From 2019-2022, he was consecutively recognized as an Outstanding Young Scientific Researcher by the Shanghai Medical Association Laboratory Medicine Branch.
📚 Publications
-
Title: Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis
Authors: A Shang, C Gu, W Wang, X Wang, J Sun, B Zeng, C Chen, W Chang, …
Publication Year: 2020
Citations: 372
-
Title: Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
Authors: A Shang, W Wang, C Gu, C Chen, B Zeng, Y Yang, P Ji, J Sun, J Wu, …
Publication Year: 2019
Citations: 147
-
Title: Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression
Authors: A Shang, C Gu, C Zhou, Y Yang, C Chen, B Zeng, J Wu, W Lu, W Wang, …
Publication Year: 2020
Citations: 100
-
Title: Tumor microenvironment: lactic acid promotes tumor development
Authors: Y Gao, H Zhou, G Liu, J Wu, Y Yuan, A Shang
Publication Year: 2022
Citations: 80
-
Title: Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1
Authors: A Shang, X Wang, C Gu, W Liu, J Sun, B Zeng, C Chen, P Ji, J Wu, …
Publication Year: 2020
Citations: 77
-
Title: Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer
Authors: AQ Shang, J Wu, F Bi, YJ Zhang, LR Xu, LL Li, FF Chen, WW Wang, …
Publication Year: 2017
Citations: 77
-
Title: Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p
Authors: AQ Shang, WW Wang, YB Yang, CZ Gu, P Ji, C Chen, BJ Zeng, JL Wu, …
Publication Year: 2019
Citations: 70
-
Title: IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
Authors: J Cui, J Tian, W Wang, T He, X Li, C Gu, L Wang, J Wu, A Shang
Publication Year: 2021
Citations: 62
-
Title: miR‐381‐3p restrains cervical cancer progression by downregulating FGF7
Authors: A Shang, C Zhou, G Bian, W Chen, W Lu, W Wang, D Li
Publication Year: 2019
Citations: 62
-
Title: Vaginal microecological characteristics of women in different physiological and pathological period
Authors: L Shen, W Zhang, Y Yuan, W Zhu, A Shang
Publication Year: 2022
Citations: 59
🔚 Conclusion
With a strong academic background, leadership in clinical laboratory medicine, and groundbreaking research in tumor immunology and molecular diagnostics, he continues to make significant contributions to medical science. His extensive experience, prestigious awards, and influential publications highlight his dedication to advancing clinical diagnostics and improving patient outcomes.
